• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Past Event

Partnerships for Health System Innovation and Improvement

Many countries around the world are experiencing strains on their healthcare systems. Innovation has the potential to support healthcare systems to strive for improved productivity to transform limited resources into valued outcomes. However, the adoption and uptake of innovation is…

Type

Commissioned Webinar

Date

12/09/23 03:00 pm

Location

Virtual

Many countries around the world are experiencing strains on their healthcare systems. Innovation has the potential to support healthcare systems to strive for improved productivity to transform limited resources into valued outcomes. However, the adoption and uptake of innovation is often hampered by a variety of barriers concerning technological advances, health system complexity, and stakeholder engagement.

Overcoming barriers to innovation adoption in health systems requires a breadth of solutions and the involvement of different stakeholder groups. Multistakeholder partnerships can remove silos, enhance knowledge exchange, conduct additional research on technology and implementation, and influence policy. This webinar will explore the use of such partnerhips as a solution to overcoming the barriers that impede efficiency enhancement and innovation.

This webinar includes:

    • An overview of the role of innovation in health system efficiency and barriers that impede the adoption of innovation.
    • Real-world examples of multistakeholder partnerships and how they addressed barriers to the adoption of innovation
    • An opportunity to have questions answered by an expert panel

 

THE PANEL

Dr Jacqueline Barry | Chief Clinical Officer, Cell and Gene Therapy Catapult

Dr Barry joined Cell and Gene Therapy Catapult as Director of Regulatory Affairs and has since been promoted to Chief Clinical Officer. Prior to this, she worked at the Scottish National Blood Transfusion Service in several senior regulatory and quality positions. She has held a number of post-Doctoral academic posts at the University of Edinburgh, studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell-based medicinal products and therapies.

Maria Vidal-Read | Head of Programme for the international Fast-Track Cities Initiative London Leadership Group

Maria Vidal-Read MCIPR is Head of Programme for the international Fast-Track Cities initiative in London. Driving the London Leadership Group to deliver the United Nations targets of zero new HIV transmissions, zero preventable deaths, zero stigma and everyone living well with HIV by 2030. Maria has over 25 years experience in communications, engagement and programme management working on public health programmes in England.

Margherita Neri | Principal Economist, Office of Health Economics

Margherita is an economist, with expertise in health system efficiency, productivity, and methods for health technology value assessment. Her current research interests include the evaluation of interventions and policies that improve health system’s resilience and performance in the face of scarce resources and high pressure. She has worked on methods and frameworks assessing the value of health technologies with large socioeconomic benefits. She also researches on the topic of healthcare efficiency measurement and the determinants of productivity, with a focus on primary care.

This webinar is intended to be useful for a wide range of stakeholders with an interest in health system efficiency and the role of innovation (including but not limited to: decision makers, regulators , academics, health data scientists and industry.

This webinar is commissioned and funded by Gilead.

 

 

  • Health Care Systems

Related Events

Eco-conscious car journeying through forest landscape, Earth pla
  • Past Event
  • Annual Lecture
  • July 2023

OHE Annual Lecture 2023 | The ECO-nomics of Health in a Shifting Climate: Fostering Well-being, Sustainable Livelihoods, and a Greener Future

Read more
cape-town-2575437
  • Past Event
  • July 2023

OHE at IHEA 2023

Read more
sustainaibiity
  • Past Event
  • OHE Webinar
  • Sponsored Webinar
  • May 2023

Supporting Sustainability in the Era of Green Pharmaceuticals

Read more
ISPOR Boston 2023
  • Past Event
  • May 2023

OHE at ISPOR 2023

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!